Literature DB >> 8259271

Timing of amblyopia therapy relative to strabismus surgery.

G C Lam1, M X Repka, D L Guyton.   

Abstract

BACKGROUND: It is taught that amblyopia must be fully reversed before surgery for esotropia is undertaken to achieve the best surgical outcome. In some cases, this means delaying surgery for many months. The alternative of operating early, before the completion of amblyopia therapy, and continuing to treat the amblyopia postoperatively has not been evaluated previously.
METHODS: Forty-seven children younger than 8 years of age were identified with a history of both amblyopia and esotropia. They had no other ocular, medical, or neurologic abnormalities. They had no prior strabismus surgery. Of these 47 patients, 26 had their amblyopia fully treated before surgery, and 21 underwent surgery before completing amblyopia therapy. Five of the latter group did not require amblyopia therapy after surgery even though they were still amblyopic before operation. The motor outcome was assessed by comparing the motor alignment at 6 and 0.33 m using accommodative targets in primary position before surgery, at 6 months after surgery, and at the child's most recent visit. Motor success was defined in this study as a postoperative deviation at distance fixation of 8 prism diopters or less. The sensory result was assessed by comparing the frequency of detectable stereoacuity.
RESULTS: The treatment groups did not differ significantly in age, depth of amblyopia, refractive error, or preoperative angle. There was no significant difference detected in motor or sensory outcome whether amblyopia was fully or only partially treated before surgery.
CONCLUSION: Performing corrective surgery in children with esotropia before full resolution of amblyopia is safe and efficient if the amblyopia therapy is continued after surgery. This strategy permits earlier surgery without postponing the operation until full resolution of amblyopia. The finding that five patients did not require amblyopia therapy after surgery suggests that eye re-alignment itself can help reverse amblyopia in some cases.

Entities:  

Mesh:

Year:  1993        PMID: 8259271     DOI: 10.1016/s0161-6420(13)31403-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets.

Authors:  J T Flynn; G Woodruff; J R Thompson; F Hiscox; W Feuer; J Schiffman; A Corona; L K Smith
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  The effect of amblyopia therapy on ocular alignment.

Authors:  Michael X Repka; Jonathan M Holmes; B Michele Melia; Roy W Beck; Matthew D Gearinger; Susanna M Tamkins; David T Wheeler
Journal:  J AAPOS       Date:  2005-12       Impact factor: 1.220

3.  Strabismus surgery before versus after completion of amblyopia therapy in children.

Authors:  Sanita Korah; Swetha Philip; Smitha Jasper; Aileen Antonio-Santos; Andrew Braganza
Journal:  Cochrane Database Syst Rev       Date:  2014-10-15

4.  The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies.

Authors:  J T Flynn; J Schiffman; W Feuer; A Corona
Journal:  Trans Am Ophthalmol Soc       Date:  1998

5.  Current concepts in the management of amblyopia.

Authors:  Blanca Ruiz de Zárate; Jaime Tejedor
Journal:  Clin Ophthalmol       Date:  2007-12

6.  Prevalence of amblyopia in primary school children in Qassim province, Kingdom of Saudi Arabia.

Authors:  Yousef Homood Aldebasi
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar

Review 7.  Management of amblyopia in pediatric patients: Current insights.

Authors:  Sagnik Sen; Pallavi Singh; Rohit Saxena
Journal:  Eye (Lond)       Date:  2021-07-07       Impact factor: 3.775

8.  Reduction of deviation angle during occlusion therapy: in partially accommodative esotropia with moderate amblyopia.

Authors:  Bo Young Chun; Soon Jae Kwon; Sun Hwa Chae; Jung Yoon Kwon
Journal:  Korean J Ophthalmol       Date:  2007-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.